US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 4.7200
  • +0.0400+0.85%
Close Dec 13 16:00 ET
  • 4.5200
  • -0.2000-4.24%
Post 20:01 ET
3.36MMarket Cap-0.47P/E (TTM)

ReShape Lifesciences Key Stats

ReShape Lifesciences Q3 2024 Earnings Date

Currency:USDNov 14, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
2.29M
--
+6.36%
EPS
--
-3.11
--
+94.76%
No Data

ReShape Lifesciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--

Unlock Free Earnings Estimates

ReShape Lifesciences Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.